GT Metabolic Solutions
PrivateLast Round
Series C
Oct 28, 2026
Total Funding Raised
$38.2M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
GT Metabolic Solutions operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Series C round in October 2026.
GT Metabolic Solutions is a medical device company that develops and manufactures magnetic compression anastomosis technologies for minimally invasive bariatric, metabolic, and digestive surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GT Metabolic Solutions Comparables
Compare GT Metabolic Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GI Windows Surgical | 87% | |
| Nitinotes Ltd. | 79% | |
| Levita Magnetics | 78% |
For institutional investors. Book with your work email.
GT Metabolic Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 28, 2026 | ||||
| Series B | Mar 20, 2024 | ||||
| Series B | Nov 6, 2023 | ||||
| Series A | Jul 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GT Metabolic Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Series B |
| Krillion Ventures | Series B |
| Ceros Capital Markets | Series B, Series A |
| J.P. Morgan Life Sciences Private Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2026
Led by J.P. Morgan Life Sciences Private Capital.
- Mar 20, 2024
$25M round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 28, 2026
On Oct 28th '26, GT Metabolic Solutions, Inc. continues the global commercial launch of its novel linear magnetic anastomosis system, which provides an incisionless, sutureless, staple-free, and reversible technique for creating gastrointestinal compression anastomoses.
For institutional investors. Book with your work email.
GT Metabolic Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GT Metabolic Solutions's valuation, stock price, and market status.
Is GT Metabolic Solutions a public or private company?
GT Metabolic Solutions is a private company.
What is the current stock price of GT Metabolic Solutions?
GT Metabolic Solutions is a private company, so its shares have no public market price. Caplight tracks GT Metabolic Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GT Metabolic Solutions worth (valuation)?
Valuation information for GT Metabolic Solutions is not publicly available.
Can I buy GT Metabolic Solutions stock?
GT Metabolic Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GT Metabolic Solutions's last funding round?
GT Metabolic Solutions's most recent funding round was Series C on October 28, 2026.
Who are the main investors in GT Metabolic Solutions?
Key investors in GT Metabolic Solutions include Ceros Capital Markets, J.P. Morgan Life Sciences Private Capital.
Will GT Metabolic Solutions IPO soon?
No public IPO plans have been announced for GT Metabolic Solutions.
How can I track GT Metabolic Solutions secondary market activity?
Caplight tracks bids, offers, and trades in GT Metabolic Solutions's shares on secondary markets.